The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.

Tarazi, Frank I; Riva, Marco A

Tarazi, Frank I; Riva, Marco A.

Affiliation

Tarazi FI; McLean Hospital, Harvard Medical School, Department of Psychiatry and Neuroscience , 115 Mill Street, Belmont, MA 02478 , USA +1 617 855 3176 ; +1 617 855 3479 ; ftarazi@hms.harvard.edu.

Expert Opin Drug Discov ; 8(10): 1297-307, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23837554

Subject(s)

Antipsychotic Agents/therapeutic use; Behavior, Animal/drug effects; Isoindoles/therapeutic use; Schizophrenia/drug therapy; Thiazoles/therapeutic use; Animals; Antipsychotic Agents/chemistry; Antipsychotic Agents/pharmacology; Depression/drug therapy; Depression/metabolism; Depression/psychology; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Isoindoles/chemistry; Isoindoles/pharmacology; Lurasidone Hydrochloride; Schizophrenia/metabolism; Schizophrenia/physiopathology; Thiazoles/chemistry; Thiazoles/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Thiazoles / Antipsychotic Agents / Behavior, Animal / Isoindoles Type of study: Prognostic_studies Language: En Journal: Expert Opin Drug Discov Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google